Vista Pharmaceuticals Ltd.
7.07-0.2 (-2.75%)
27 Jul, 12:00 AM
Annual Reports and Financial Documents
Vista Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
Corporate Announcements and Regulatory Filings
Vista Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
- Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.03.2026Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve 1. Audited financial ....
- Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
- Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter And Nine Months Ended 31.12.2025.Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/02/2026 ,inter alia, to consider and approve 1. Unaudited financial ....
- Board Meeting Intimation for 1. Unaudited Financial Results For The Quarter Ended 30.09.2025.Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. Unaudited financial ....
Frequently Asked Questions
Where can I download the annual report of Vista Pharmaceuticals Ltd.?
Annual reports of Vista Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Vista Pharmaceuticals Ltd.?
Quarterly earnings results and presentations of Vista Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Vista Pharmaceuticals Ltd. publish earnings call transcripts?
Earnings call transcripts of Vista Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Vista Pharmaceuticals Ltd.?
Investor presentations and annual day presentations of Vista Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Vista Pharmaceuticals Ltd.?
Corporate announcements and regulatory filings of Vista Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Vista Pharmaceuticals Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Vista Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Vista Pharmaceuticals Ltd.?
The ISIN (International Securities Identification Number) of Vista Pharmaceuticals Ltd. is INE427C01021. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Vista Pharmaceuticals Ltd. listed?
Vista Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is 524711-BOM and the BSE code is -.
Where can I find the shareholding pattern of Vista Pharmaceuticals Ltd.?
The quarterly shareholding pattern of Vista Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Vista Pharmaceuticals Ltd. on Sharpely?
Share price data for Vista Pharmaceuticals Ltd. is updated as of 27 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.